MedTrace Logo

China Extracorporeal Life Support Registry

NCT04158479 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 20000

Last updated 2024-04-09

No results posted yet for this study

Summary

Extracorporeal life support (ECLS), also known as extracorporeal membrane oxygenation (ECMO), is an extracorporeal technique of providing effective cardiac and respiratory support to patients with lungs and/or heart failure. There was a growth in ECLS cases, centers, and center scale in China during the past decade.

This multi-center registry was conducted by Chinese Society of Extracorporeal Life Support. The objectives were to investigate China statistics of ECLS and to evaluate the short-term and long-term outcomes of patients with ECLS.

Conditions

  • Cardiogenic Shock
  • Cardiac Arrest
  • Heart Failure
  • Acute Respiratory Distress Syndrome
  • Acute Respiratory Failure

Interventions

DEVICE

ECMO

ECMO for circulatory and/or respiratory support

Sponsors & Collaborators

  • Beijing Anzhen Hospital

    lead OTHER

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-01-01
Primary Completion
2030-12-31
Completion
2030-12-31

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04158479 on ClinicalTrials.gov